A carregar...
P1319: TREATMENT WITH MIDOSTAURIN AND OTHER FLT3 TARGETING INHIBITORS IS ASSOCIATED WITH AN INCREASED RISK OF CARDIOVASCULAR ADVERSE EVENTS IN PATIENTS WITH FLT3 MUTATED AML WHO UNDERWENT ALLOGENEIC HCT
Na minha lista:
| Publicado no: | HemaSphere |
|---|---|
| Main Authors: | , , , , , , , , , , |
| Formato: | Artigo |
| Publicado em: |
Wiley
2023-08-01
|
| Acesso em linha: | http://journals.lww.com/10.1097/01.HS9.0000972164.39454.e5 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|